GlaxoSmithKline PLC (NYSE:GSK)

43.27
Delayed Data
As of Oct 23
 +0.75 / +1.76%
Today’s Change
36.41
Today|||52-Week Range
43.31
+13.24%
Year-to-Date
Is AnaptysBio a Buy?
Oct 23 / MotleyFool.com - Paid Partner Content
Will The Pace of M&A Pick Up Following The Biotech Sector’s Pounding?
Oct 11 / MotleyFool.com - Paid Partner Content
Better Buy: GlaxoSmithKline vs. Merck
Oct 15 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close42.52
Today’s open43.10
Day’s range42.96 - 43.31
Volume3,335,414
Average volume (3 months)2,301,449
Market cap$106.1B
Data as of 6:30pm ET, 10/23/2019

Growth & Valuation

Earnings growth (last year)+143.10%
Earnings growth (this year)-6.95%
Earnings growth (next 5 years)+3.50%
Revenue growth (last year)+5.72%
P/E ratio18.9
Price/Sales2.31
Price/Book18.85

Competitors

 Today’s
change
Today’s
% change
LLYEli Lilly and Co-2.44-2.22%
SNYSanofi+0.45+0.99%
ABBVAbbVie-0.12-0.15%
AZNAstraZeneca+0.77+1.75%
Data as of 6:30pm ET, 10/23/2019

Financials

Last reporting date--
EPS forecast (this quarter)$0.81
Annual revenue (last year)$41.1B
Annual profit (last year)$4.8B
Net profit margin11.75%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
Brentford, Greater London

Forecasts